This is a pilot study designed to acquire data on the added value of hydrodissection when using a corticosteroid injection as a treatment for patients with carpal tunnel syndrome. Hydrodissection is part of a standard clinical care injection under ultrasound guidance in which the fluid is used to separate the nerve from surrounding structures.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
20
Additional 3cc's of saline is used to establish an increase in hydrodissection during routine treatment.
Corticosteroid and lidocaine injection without additional saline is used as routine treatment.
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Tolerance
Acquire data on the added value of hydrodissection when using injection as a treatment for patients with Carpal Tunnel Syndrome (CTS). Questionnaires will be used to assess level of tolerance using a 10 point Likert Scale.
Time frame: 6 months
Clinical Severity of Carpal Tunnel Syndrome
The Boston Carpal Tunnel Assessment questionnaire will be used to assess both symptom severity and functional status using a 19 item questionnaire with scores between values 1-5.
Time frame: 6 months
Overall Pain
The visual analog scale will be used to assess overall pain. This is a 1-10 Likert scale.
Time frame: 6 months
Additional Treatment
After 6 months patients will be asked whether they have had additional treatment for their Carpal Tunnel Syndrome after the ultrasound guided injection. The date, location, and time frame of the additional treatment will be recorded.
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.